News

FDA approves idelalisib for three leukemia and lymphoma indications
- Author:
- Elizabeth Mechcatie
Publish date: July 23, 2014
News

Study provides cancer risk estimates among women undergoing morcellation
- Author:
- Elizabeth Mechcatie
Publish date: July 22, 2014
News

Study provides cancer risk estimates among women undergoing morcellation
- Author:
- Elizabeth Mechcatie
Publish date: July 22, 2014
News

FDA approves C1-esterase inhibitor for hereditary angioedema
- Author:
- Elizabeth Mechcatie
Publish date: July 17, 2014
News

Viral reactivation common in septic patients
- Author:
- Elizabeth Mechcatie
Publish date: July 14, 2014
News

FDA panel recommends informed consent, labeling changes to address morcellator risk
- Author:
- Elizabeth Mechcatie
Publish date: July 12, 2014
Video
VIDEO: ‘Improve – but do not abandon – power morcellation’
- Author:
- Elizabeth Mechcatie
Publish date: July 11, 2014
News
FDA panel addresses risks of power morcellators in fibroid surgery
- Author:
- Elizabeth Mechcatie
Publish date: July 11, 2014
News

FDA approves belinostat for peripheral T-cell lymphoma
- Author:
- Elizabeth Mechcatie
Publish date: July 8, 2014
News

FDA grants "breakthrough" status to investigational T-cell therapy for relapsed/refractory ALL
- Author:
- Elizabeth Mechcatie
Publish date: July 7, 2014
News

FDA grants "breakthrough" status to investigational T-cell therapy for relapsed/refractory ALL
- Author:
- Elizabeth Mechcatie
Publish date: July 7, 2014
News

FDA approves inhaled insulin for adults, with safety-monitoring plan
- Author:
- Elizabeth Mechcatie
Publish date: June 27, 2014
News

FDA Approves Inhaled Insulin for Adults
- Author:
- Elizabeth Mechcatie
Publish date: June 27, 2014
News

Phase III trial results needed before PARP inhibitor approved for ovarian cancer indication
- Author:
- Elizabeth Mechcatie
Publish date: June 26, 2014
News

FDA’s olmesartan probe showed no increased CV risk in diabetes
- Author:
- Elizabeth Mechcatie
Publish date: June 25, 2014